Lange, J.M.A.

patient count hypertension therapy treatment nvp therapy study blood pressure group blood pressure prevalence population health haart namibia antiretroviral therapy antiretroviral household tanzania t-cell survey disease nadir kenya treatment-experienced patients control nigeria interruption factor netherland treatment-naive patients respondent nevirapine amsterdam treatment interruption insurance country level analysis university risk factors systolic blood pressure erasmus university rotterdam sample systolic nvp-based combination therapy status discontinuation body mass index treatment-naive pretreated patients diastolic africa control group diabetes consumption march plasma self report study populations cvd risk factors model center asian signi insurance program sub-saharan women volume 48 weeks signi ficantly world report sub-saharan africa adult 350 cells /mm score increase table